Search results
Lok Sabha elections 2024: Elderly leprosy patients cast their vote
Mid Day· 2 hours agoAccording to centre officials, among those who cast their votes were Narayan Madavi, 76, Pundlik...
Merck stops testing combo drug for skin cancer as more patients discontinue - ET HealthWorld |...
The Economic Times· 3 hours agoLondon: Merck said on Monday it had discontinued an experimental combination treatment testing a new...
Wegovy weight loss sustained for four years in trial, Novo Nordisk says - ET HealthWorld | Pharma
The Economic Times· 3 hours agoNovo presented the new long-term data at the European Congress on Obesity in Venice...loss," Martin...
Jaundice outbreak in Vengoor panchayat with 180 cases | Kochi News - Times of India
The Times of India· 5 hours agoKochi: The number of jaundice patients in Vengoor panchayat has risen to 180. The local body will convene a meeting on Tuesday to form a help group to raise funds to meet the treatment ...
Student battles cancer, scores 94.8% | Kolkata News - Times of India
The Times of India· 5 hours agoDiagnosed with cancer just before his exams on Feb 16, and amidst uncertainty and fear, he found the strength to persevere. “I had this constant abdominal ...
US stock markets: Incyte shares climb over 8% on $2 billion stock buyback plan
Livemint· 11 hours agoAt 1:13 p.m. EDT, Incyte Corp shares were at $57.27, 7.93 per cent higher in New York
Spike in jaundice cases at Vengoor in Ernakulam
The Hindu· 12 hours agoJaundice outbreak in Vengoor panchayat in the district has worsened with the number of cases going up to 175 from nearly 50 reported in the end of April. A 34-year-old woman died, and ...
Heart Health: Watch Out For These Signs And Symptoms Of High Cholesterol Levels
NDTV· 12 hours agoCholesterol is the waxy substance found in your blood. When found in excess, it can increase your...
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology· 12 hours agoAugtyro, an orally administered tyrosine kinase inhibitor (TKI) designed to inhibit specific kinases...
Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
Pharmaceutical Technology· 13 hours agoThe therapy is designed to induce an antibody response against those amyloid beta versions thereby...
